Prospective Validation of Adaptive Radiotherapy (ART) in Patients With Head and Neck Tumors
Recruiting
N/A
Interventional Study
Head and Neck Cancer
Adaptive Radiotherapy
Radiation
Optimized Treatment
Protection of Organs at Risk
Dysphagia Reduction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 50 (estimated)
- Sponsor
- University Hospital, Essen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Adaptive radiotherapy (ART) includes image-guided radiotherapy (IGRT) and also offers further possibilities for plan adaptation. A particularly high benefit can be expected for patients in whom the clinical target volume (CTV) can show a significant change in shape from fraction to fraction due to anatomical deviations. The shape and position constancy of the CTV during the course of the series is…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. ECOG 0-1
2. Histopathology confirmation
3. Compliance
4. Tumor in the head and neck region
5. Indication for radiotherapy
Exclusion Criteria:
1\. Pregnancy
Contacts
Maja PD Dr. med. Guberina, PD Dr. med. (MD), specialist
+492017232321
CONTACT